Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
r-hFSH + r-hLH from COS day 1 in unexpected poor ovarian response
ChiCTR2400086595Phase 4Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of follitropin alfa and lutropin alfa in poor ovarian response (POR), sponsored by Peking University Third Hospital. Primary endpoint: Number of oocytes retrieved. Started Jul 2024; status: recruiting.
02
Drugs
follitropin alfalutropin alfa
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on ChiCTR2400086595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086595.